Zusammenfassung
Vor der Verordnung eines Medikamentes sollten 2 Fragen gestellt und, wenn möglich, geklärt werden:
-
1.
Wie ist die Pathogenese der Erkrankung, die behandelt werden muß, d.h. welche pathologischen Veränderungen liegen dem klinischen Bild zugrunde?
-
2.
Wie wirkt das vorgesehene Medikament und welches Wirkprofil besitzt es?
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Literatur
Dikshit K, Vyden JK, Forrester JS, Chatterjee K, Praksha R, Swan HJC (1973) Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure. N Engl J Med 288: 1087–1090
Johnston GD, Hiatt WR, Nies AS, Payne NA, Murphy RC, Gerber IG (1983) Factors modifying the early non diuretic vascular effect of furosemide in man. The possible role of renal prostaglandins. Circ Res 53: 630–635
Margini F, Niarchos AP (1980) Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema. Am J Cardiol 45: 841–847
Fracnis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN (1985) Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 103: 1–6
Guyton AC (1965) Interstitial fluid pressure: II. Pressure-Volume Curves of interstitial space. Circ Res 16: 452–460
Brater DC (1981) Resistance to diuretics: Emphasis on pharmacological perspective. Drugs 22: 477–494
Keller E, Hoppe-Seyler G, Mumm R, Schollmeyer P (1981) Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide. Eur J Clin Pharmacol 20: 27–33
Hasenfuß G, Holubarsch CH, Herzog CH, Knauf H, Spahn H, Mutschler, E. Just H (1986) Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide. Clin Cardiol (im Druck)
Lopez-Novaa JM, Santos JC, Caramelo C, Fernandez-Munoz D, Blanchart A, Hernando L (1984) Mechanisms of the impaired diuretic and natriuretic response to a sustained and moderate saline infusion in rat with experimental cirrhosis. Hepatology 4: 419–423
Skorecki KL, Brenner BM (1982) Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. Am J Med 72: 323–338
Ichinawa I, Pfeffer MA, Hostetter TH, Brenner BM (1984) Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 55: 669–675
Heck I, Kikis D, Knauer I, Stumpe KO, Krück F (1985) Therapie der Herzinsuffizienz Schweregrad III, IV durch Hemmung des Angiotensin-Converting-Enzyms. Klin Wochenschr 63 (Suppl IV) 12
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Knauf, H., Hasenfuss, G., Just, H., Mutschler, E. (1986). Kardiovaskuläre Wirkungen von Diuretika. In: Krück, F., Schrey, A. (eds) Diuretika III. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71487-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-71487-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71489-4
Online ISBN: 978-3-642-71487-0
eBook Packages: Springer Book Archive